StockMacro
Menu

Illumina

$192.82 +33% in 6 monthsMarket cap $29.2B

ILMN on XNAS, Technology, Illumina Inc, job postings

Measures activity, not value. Not investment advice.

Insiders sold $270.2M in 90 days while shares fell 32% in a month, still up 62% in a year.

  • BadShort interest 10.6M shares, 1.4 times a year earlier
  • GoodNew institutional positions 245, 2.6 times a year earlier

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 27 Sep 2026

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Industry
Laboratory analytical instruments (Technology)
Employees
8,650
Website
illumina.com
Listed
Nasdaq, US
Last results
29 Oct 2026
Next results
expected around 12 Jan 2027 (an estimate: a year ago it reported on 13 Jan 2026)
Revenue and net income per quarter. Quarter to 27 Sep 2026: revenue $1.1B, net income $220.0M.
Quarter to 2 Jan 2022: revenue $1.2B, net income $113.0MQuarter to 2 Jan 2022: revenue $1.2B, net income $113.0MQuarter to 3 Apr 2022: revenue $1.2B, net income $86.0MQuarter to 3 Apr 2022: revenue $1.2B, net income $86.0MQuarter to 3 Jul 2022: revenue $1.2B, net income -$535.0MQuarter to 3 Jul 2022: revenue $1.2B, net income -$535.0MQuarter to 2 Oct 2022: revenue $1.1B, net income -$3.8BQuarter to 2 Oct 2022: revenue $1.1B, net income -$3.8BQuarter to 1 Jan 2023: revenue $1.1B, net income -$139.0MQuarter to 1 Jan 2023: revenue $1.1B, net income -$139.0MQuarter to 2 Apr 2023: revenue $1.1B, net income $3.0MQuarter to 2 Apr 2023: revenue $1.1B, net income $3.0MQuarter to 2 Jul 2023: revenue $1.2B, net income -$234.0MQuarter to 2 Jul 2023: revenue $1.2B, net income -$234.0MQuarter to 1 Oct 2023: revenue $1.1B, net income -$754.0MQuarter to 1 Oct 2023: revenue $1.1B, net income -$754.0MQuarter to 31 Dec 2023: revenue $1.1B, net income -$176.0MQuarter to 31 Dec 2023: revenue $1.1B, net income -$176.0MQuarter to 31 Mar 2024: revenue $1.1B, net income -$126.0MQuarter to 31 Mar 2024: revenue $1.1B, net income -$126.0MQuarter to 30 Jun 2024: revenue $1.1B, net income -$2.0BQuarter to 30 Jun 2024: revenue $1.1B, net income -$2.0BQuarter to 29 Sep 2024: revenue $1.1B, net income $705.0MQuarter to 29 Sep 2024: revenue $1.1B, net income $705.0MQuarter to 29 Dec 2024: revenue $1.1B, net income $186.0MQuarter to 29 Dec 2024: revenue $1.1B, net income $186.0MQuarter to 30 Mar 2025: revenue $1.0B, net income $131.0MQuarter to 30 Mar 2025: revenue $1.0B, net income $131.0MQuarter to 29 Jun 2025: revenue $1.1B, net income $235.0MQuarter to 29 Jun 2025: revenue $1.1B, net income $235.0MQuarter to 28 Sep 2025: revenue $1.1B, net income $150.0MQuarter to 28 Sep 2025: revenue $1.1B, net income $150.0MQuarter to 28 Dec 2025: revenue $1.2B, net income $334.0MQuarter to 28 Dec 2025: revenue $1.2B, net income $334.0MQuarter to 29 Mar 2026: revenue $1.1B, net income $134.0MQuarter to 29 Mar 2026: revenue $1.1B, net income $134.0MQuarter to 28 Jun 2026: revenue $1.2B, net income $207.0MQuarter to 28 Jun 2026: revenue $1.2B, net income $207.0MQuarter to 27 Sep 2026: revenue $1.1B, net income $220.0MQuarter to 27 Sep 2026: revenue $1.1B, net income $220.0M
2 Jan 2022RevenueNet incomeNet losstallest bar $3.8B27 Sep 2026
See the numbers
Quarter toRevenueNet income
27 Sep 2026$1.1B$220.0M
28 Jun 2026$1.2B$207.0M
29 Mar 2026$1.1B$134.0M
28 Dec 2025$1.2B$334.0M
28 Sep 2025$1.1B$150.0M
29 Jun 2025$1.1B$235.0M
30 Mar 2025$1.0B$131.0M
29 Dec 2024$1.1B$186.0M
29 Sep 2024$1.1B$705.0M
30 Jun 2024$1.1B-$2.0B
31 Mar 2024$1.1B-$126.0M
31 Dec 2023$1.1B-$176.0M
1 Oct 2023$1.1B-$754.0M
2 Jul 2023$1.2B-$234.0M
2 Apr 2023$1.1B$3.0M
1 Jan 2023$1.1B-$139.0M
2 Oct 2022$1.1B-$3.8B
3 Jul 2022$1.2B-$535.0M
3 Apr 2022$1.2B$86.0M
2 Jan 2022$1.2B$113.0M
Fundamentals, 12 months to 27 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $4.5B $4.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +5.8% +5.0%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $895.0M $702.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $5.81 $4.46
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 67.9% 66.2% 49.6%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 21.2% 18.2% -7.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 19.7% 16.4% -10.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 32.4% -17.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $1.1B $1.0B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $1.3B $1.3B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.8B $2.0B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $452.0M $714.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.57 0.45
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $20.80
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 32.6 33.4
P/SPrice to sales: market cap divided by revenue of the last 12 months. 6.4 4.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 6.5 4.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 9.3 2.4

Latest = 12 months to 27 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
IlluminaILMN (this company) $29.2B32.66.4+5.8%19.7%
Mettler-Toledo InternationalMTD $33.2B35.57.9+6.5%22.2%
Agilent TechnologiesA $48.0B33.46.5+8.6%19.5%
RevvityRVTY $16.2B64.05.5+4.6%8.6%
AvantorAVTR $10.1B29.81.5+0.9%5.1%
WatersWAT $86.6B88115.4+81%1.8%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$270.2M

bought $0, sold $270.2M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+20%

1,100 13F filers vs 918

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

160.5M shares held by 13F filers (30 Sep 2026) of 151.2M outstanding (23 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.3%

8.0M shares sold short (30 Oct 2026) of 151.2M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.7

8.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.7%

7.9M shares sold short in the report before, 8.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

65%

65% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 61%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-26%

84 vs 114 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+4.2%

$1.1B vs $1.1B (quarter ended 27 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+29%

$40.0M vs $31.0M (quarter ended 27 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$32.9M

the 12 months before: $31.6M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$1.2M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

58

58 articles in the last 7 days; its usual week has 7.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

7.7×

58 articles in the last 7 days; its usual week has 7.5.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New institutional positions 245, 2.6× a year earlier
  • Short interest 10.6M, 1.4× a year earlier

Price $192.82 on 20 Nov 2026, +62% over 12 months (12-month range $114.44 to $293.69)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $720.6M in the last 12 months (the 12 months before: $1.6M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 84 published in the last 12 months, -26% on the 12 months before.
Revenue per quarter. Revenue $1.1B in the latest quarter, +4.2% on a year earlier.
Capital spending per quarter. Capital spending $40.0M in the latest quarter, +29% on a year earlier.
Institutional holders (13F filers). 1,100 13F filers reported holding it in the latest 13F quarter, +51% on a year earlier.
Federal obligations. Federal obligations: $27.0M published in the last 12 months, -16% on the 12 months before.
Lobbying spend. Lobbying spend: $1.2M published in the last 12 months, -41% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeMany funds opening a new position: many funds opening a new position, 245 vs usual 105 (2026-09-30); 2.6x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 10.6M vs usual 7.3M (2026-09-15); 1.4x the same period a year earlier
13 Aug 20268-K and other filingsA major agreement ended
23 Jun 20268-K and other filingsDirector or officer change
19 May 2026Sharp changeWikipedia attention spike: wikipedia attention spike, 6,435 vs usual 846.50 (2026-05-11..2026-05-17); 4.5x the same week a year earlier
7 May 2026Lobbying filingnew lobbying registration (THORN RUN PARTNERS)
2 Apr 20268-K and other filingsDirector or officer change
17 Feb 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 55.0M vs usual 31.5M (2025-12-28); 1.9x the same period a year earlier
30 Jan 20268-K and other filingsCompleted an acquisition or asset sale
13 Jan 2026Lobbying filinglobbying engagement terminated (S-3 GROUP)
8 Jan 20268-K and other filingsDirector or officer change
8 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Oct 2025Lobbying filinglobbying engagement terminated (FARRAGUT PARTNERS LLP)
10 Jul 2025Lobbying filingnew lobbying registration (MILLER STRATEGIES, LLC)
22 May 20258-K and other filingsDirector or officer change
25 Mar 20258-K and other filingsDirector or officer change
24 Mar 20258-K and other filingsDirector or officer change
24 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Feb 2025Sharp changeWikipedia attention spike: wikipedia attention spike, 5,355 vs usual 1,291 (2025-02-03..2025-02-09); 3.5x the same week a year earlier
17 Jan 2025Lobbying filinglobbying engagement terminated (SIDLEY AUSTIN LLP)
17 Dec 2024Sharp changeShort interest spike: short interest spike, 7.2M vs usual 5.0M (2024-11-29); 1.4x the same period a year earlier
19 Nov 2024Sharp changeShort interest spike: short interest spike, 6.7M vs usual 5.0M (2024-10-31); 1.3x the same period a year earlier
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 124 vs usual 87 (2024-09-30); 2.1x the same period a year earlier
29 Oct 2024Sharp changeShort interest spike: short interest spike, 6.8M vs usual 5.0M (2024-10-15); 1.2x the same period a year earlier
23 Oct 2024Lobbying filingnew lobbying registration (S-3 GROUP)
3 Oct 20248-K and other filingsDirector or officer change
3 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Sep 20248-K and other filingsA major agreement ended
22 Jul 2024Lobbying filinglobbying engagement terminated (DLA PIPER LLP (US))
24 Jun 20248-K and other filingsCompleted an acquisition or asset sale
3 Jun 20248-K and other filingsRestructuring costs announced
19 Apr 2024Lobbying filinglobbying engagement terminated (AKIN GUMP STRAUSS HAUER & FELD)
9 Apr 20248-K and other filingsDirector or officer change
9 Apr 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Jan 2024Lobbying filinglobbying engagement terminated (FEROX STRATEGIES)
19 Jan 2024Lobbying filinglobbying engagement terminated (CHARTWELL STRATEGY GROUP LLC)
16 Jan 2024Lobbying filinglobbying engagement terminated (DGA GROUP GOVERNMENT RELATIONS LLC)
4 Jan 20248-K and other filingsDirector or officer change
4 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Oct 2023Lobbying filingnew lobbying registration (TODD STRATEGY GROUP)
20 Oct 2023Lobbying filinglobbying engagement terminated (RAMPY NORTHRUP LLC)
20 Oct 2023Lobbying filingnew lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
19 Oct 2023Lobbying filinglobbying engagement terminated (MERCURY PUBLIC AFFAIRS, LLC)
28 Sep 2023Lobbying filingnew lobbying registration (FARRAGUT PARTNERS LLP)
11 Sep 2023Lobbying filingnew lobbying registration (AKIN GUMP STRAUSS HAUER & FELD)
8 Sep 20238-K and other filingsDirector or officer change
5 Sep 20238-K and other filingsDirector or officer change
9 Aug 20238-K and other filingsDirector or officer change
1 Aug 2023Sharp changeShort interest spike: short interest spike, 7.1M vs usual 4.4M (2023-07-14); 2.0x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 6.9M vs usual 4.3M (2023-06-30); 1.8x the same period a year earlier
26 Jun 20238-K and other filingsRestructuring costs announced
13 Jun 20238-K and other filingsDirector or officer change
7 Jun 20238-K and other filingsDirector or officer change
30 May 20238-K and other filingsDirector or officer change
30 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Feb 20238-K and other filingsDirector or officer change
1 Feb 20238-K and other filingsDirector or officer change
1 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Jan 2023Lobbying filingnew lobbying registration (DGA GROUP GOVERNMENT RELATIONS LLC)
4 Jan 20238-K and other filingsA major agreement ended
29 Nov 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.0M (2022-11-15); 2.5x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 4.8M vs usual 1.9M (2022-10-31); 2.3x the same period a year earlier
1 Nov 2022Sharp changeShort interest spike: short interest spike, 5.0M vs usual 1.9M (2022-10-14); 2.7x the same period a year earlier
18 Oct 2022Sharp changeShort interest spike: short interest spike, 4.3M vs usual 1.9M (2022-09-30); 2.1x the same period a year earlier
4 Oct 2022Sharp changeH-1B/E-3 applications change: h-1B/E-3 applications change, 40 vs usual 9.50 in the same month of earlier years (2022-05-01..2022-05-31); 3.6x the same month a year earlier
30 Sep 20228-K and other filingsDirector or officer change
27 Sep 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.9M (2022-09-15); 1.8x the same period a year earlier
16 Sep 20228-K and other filingsDirector or officer change
16 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Sep 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 1.9M (2022-08-31); 2.0x the same period a year earlier
30 Aug 2022Sharp changeShort interest spike: short interest spike, 3.5M vs usual 1.9M (2022-08-15); 1.6x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.9M (2022-07-15); 1.5x the same period a year earlier
26 Jul 2022Sharp changeLobbying spend jump: lobbying spend jump, 1.8M vs usual 350K (2022-06-30); 5.1x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.9M (2022-06-30); 1.5x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 3.4M vs usual 1.9M (2022-06-15); 1.3x the same period a year earlier
9 Jun 20228-K and other filingsDirector or officer change
9 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Jan 2022Sharp changeLobbying spend jump: lobbying spend jump, 1.4M vs usual 340K (2021-12-31); 4.1x the same period a year earlier
21 Dec 2021Lobbying filingnew lobbying registration (FEROX STRATEGIES)
Insider net buying (open market)
Month from 1 Nov 2021: -$119K published
Month from 1 Dec 2021: -$199K published
Month from 1 Jan 2022: -$340K published
Month from 1 Mar 2022: -$126K published
Month from 1 Apr 2022: -$1.6M published
Month from 1 May 2022: -$110K published
Month from 1 Jun 2022: -$54K published
Month from 1 Jul 2022: -$108K published
Month from 1 Oct 2022: -$108K published
Month from 1 Nov 2022: -$480K published
Month from 1 Dec 2022: -$106K published
Month from 1 Jan 2023: -$281K published
Month from 1 Feb 2023: -$1.2M published
Month from 1 Mar 2023: -$780K published
Month from 1 May 2023: -$1.0M published
Month from 1 Jun 2023: -$100K published
Month from 1 Jul 2023: -$95K published
Month from 1 Aug 2023: -$84K published
Month from 1 Nov 2023: -$36K published
Month from 1 Feb 2024: $992K published
Month from 1 May 2025: $1.5M published
Month from 1 Nov 2025: $61K published
Month from 1 Dec 2025: -$115K published
Month from 1 Feb 2026: -$407K published
Month from 1 May 2026: -$48.0M published
Month from 1 Jun 2026: -$107.8M published
Month from 1 Aug 2026: -$379.3M published
Month from 1 Sep 2026: -$57.2M published
Month from 1 Nov 2026: -$127.7M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 31 published
Quarter from 1 Apr 2022: 52 published
Quarter from 1 Jul 2022: 71 published
Quarter from 1 Oct 2022: 41 published
Quarter from 1 Jan 2023: 19 published
Quarter from 1 Apr 2023: 24 published
Quarter from 1 Jul 2023: 38 published
Quarter from 1 Oct 2023: 29 published
Quarter from 1 Jan 2024: 16 published
Quarter from 1 Apr 2024: 21 published
Quarter from 1 Jul 2024: 54 published
Quarter from 1 Oct 2024: 9 published
Quarter from 1 Jan 2025: 23 published
Quarter from 1 Apr 2025: 29 published
Quarter from 1 Jul 2025: 42 published
Quarter from 1 Oct 2025: 20 published
Quarter from 1 Jan 2026: 15 published
Quarter from 1 Apr 2026: 13 published
Quarter from 1 Jul 2026: 34 published
Quarter from 1 Oct 2026: 22 published
Revenue per quarter
Quarter ended 2 Jan 2022: $1.2B, +26% on a year earlier; public on 19 Feb 2022
Quarter ended 3 Apr 2022: $1.2B, +12% on a year earlier; public on 6 May 2022
Quarter ended 3 Jul 2022: $1.2B, +3.2% on a year earlier; public on 12 Aug 2022
Quarter ended 2 Oct 2022: $1.1B, +0.6% on a year earlier; public on 5 Nov 2022
Quarter ended 1 Jan 2023: $1.1B, -9.7% on a year earlier; public on 18 Feb 2023
Quarter ended 2 Apr 2023: $1.1B, -11% on a year earlier; public on 6 May 2023
Quarter ended 2 Jul 2023: $1.2B, +1.2% on a year earlier; public on 11 Aug 2023
Quarter ended 1 Oct 2023: $1.1B, +0.4% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $1.1B, +3.6% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $1.1B, -1.0% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $1.1B, -5.4% on a year earlier; public on 8 Aug 2024
Quarter ended 29 Sep 2024: $1.1B, -3.5% on a year earlier; public on 7 Nov 2024
Quarter ended 29 Dec 2024: $1.1B, -1.6% on a year earlier; public on 13 Feb 2025
Quarter ended 30 Mar 2025: $1.0B, -3.3% on a year earlier; public on 10 May 2025
Quarter ended 29 Jun 2025: $1.1B, -4.8% on a year earlier; public on 2 Aug 2025
Quarter ended 28 Sep 2025: $1.1B, +0.4% on a year earlier; public on 1 Nov 2025
Quarter ended 28 Dec 2025: $1.2B, +5.0% on a year earlier; public on 13 Feb 2026
Quarter ended 29 Mar 2026: $1.1B, +4.8% on a year earlier; public on 5 May 2026
Quarter ended 28 Jun 2026: $1.2B, +9.4% on a year earlier; public on 1 Aug 2026
Quarter ended 27 Sep 2026: $1.1B, +4.2% on a year earlier; public on 31 Oct 2026
Capital spending per quarter
Quarter ended 2 Jan 2022: $70.0M, +13% on a year earlier; public on 19 Feb 2022
Quarter ended 3 Apr 2022: $61.0M, +45% on a year earlier; public on 6 May 2022
Quarter ended 3 Jul 2022: $71.0M, +61% on a year earlier; public on 12 Aug 2022
Quarter ended 2 Oct 2022: $66.0M, +27% on a year earlier; public on 5 Nov 2022
Quarter ended 1 Jan 2023: $88.0M, +26% on a year earlier; public on 18 Feb 2023
Quarter ended 2 Apr 2023: $52.0M, -15% on a year earlier; public on 6 May 2023
Quarter ended 2 Jul 2023: $47.0M, -34% on a year earlier; public on 11 Aug 2023
Quarter ended 1 Oct 2023: $45.0M, -32% on a year earlier; public on 14 Nov 2023
Quarter ended 31 Dec 2023: $51.0M, -42% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $36.0M, -31% on a year earlier; public on 4 May 2024
Quarter ended 30 Jun 2024: $31.0M, -34% on a year earlier; public on 8 Aug 2024
Quarter ended 29 Sep 2024: $32.0M, -29% on a year earlier; public on 7 Nov 2024
Quarter ended 29 Dec 2024: $29.0M, -43% on a year earlier; public on 13 Feb 2025
Quarter ended 30 Mar 2025: $32.0M, -11% on a year earlier; public on 10 May 2025
Quarter ended 29 Jun 2025: $30.0M, -3.2% on a year earlier; public on 2 Aug 2025
Quarter ended 28 Sep 2025: $31.0M, -3.1% on a year earlier; public on 1 Nov 2025
Quarter ended 28 Dec 2025: $55.0M, +90% on a year earlier; public on 13 Feb 2026
Quarter ended 29 Mar 2026: $38.0M, +19% on a year earlier; public on 5 May 2026
Quarter ended 28 Jun 2026: $40.0M, +33% on a year earlier; public on 1 Aug 2026
Quarter ended 27 Sep 2026: $40.0M, +29% on a year earlier; public on 31 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 946; public on 14 Feb 2022
31 Mar 2022 report: 960; public on 16 May 2022
30 Jun 2022 report: 845; public on 15 Aug 2022
30 Sep 2022 report: 820; public on 14 Nov 2022
31 Dec 2022 report: 853; public on 14 Feb 2023
31 Mar 2023 report: 875; public on 15 May 2023
30 Jun 2023 report: 811; public on 14 Aug 2023
30 Sep 2023 report: 749; public on 14 Nov 2023
31 Dec 2023 report: 751; public on 14 Feb 2024
31 Mar 2024 report: 748; public on 15 May 2024
30 Jun 2024 report: 728; public on 14 Aug 2024
30 Sep 2024 report: 757; public on 14 Nov 2024
31 Dec 2024 report: 814; public on 14 Feb 2025
31 Mar 2025 report: 689; public on 15 May 2025
30 Jun 2025 report: 708; public on 14 Aug 2025
30 Sep 2025 report: 728; public on 14 Nov 2025
31 Dec 2025 report: 820; public on 17 Feb 2026
31 Mar 2026 report: 823; public on 15 May 2026
30 Jun 2026 report: 918; public on 14 Aug 2026
30 Sep 2026 report: 1,100; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $2.4M published
Month from 1 Dec 2021: $10.7M published
Month from 1 Jan 2022: $1.3M published
Month from 1 Feb 2022: $1.4M published
Month from 1 Mar 2022: $2.9M published
Month from 1 Apr 2022: $1.8M published
Month from 1 May 2022: $4.4M published
Month from 1 Jun 2022: $2.7M published
Month from 1 Jul 2022: $3.7M published
Month from 1 Aug 2022: $4.7M published
Month from 1 Sep 2022: $8.1M published
Month from 1 Oct 2022: $1.6M published
Month from 1 Nov 2022: $3.6M published
Month from 1 Dec 2022: $5.2M published
Month from 1 Jan 2023: $854K published
Month from 1 Feb 2023: $2.7M published
Month from 1 Mar 2023: $2.7M published
Month from 1 Apr 2023: $2.1M published
Month from 1 May 2023: $5.5M published
Month from 1 Jun 2023: $3.3M published
Month from 1 Jul 2023: $3.7M published
Month from 1 Aug 2023: $3.7M published
Month from 1 Sep 2023: $12.9M published
Month from 1 Oct 2023: $1.5M published
Month from 1 Nov 2023: $4.1M published
Month from 1 Dec 2023: $2.3M published
Month from 1 Jan 2024: $1.7M published
Month from 1 Feb 2024: $1.7M published
Month from 1 Mar 2024: $2.0M published
Month from 1 Apr 2024: $2.4M published
Month from 1 May 2024: $2.2M published
Month from 1 Jun 2024: $2.2M published
Month from 1 Jul 2024: $3.7M published
Month from 1 Aug 2024: $5.8M published
Month from 1 Sep 2024: $6.4M published
Month from 1 Oct 2024: $1.5M published
Month from 1 Nov 2024: $2.8M published
Month from 1 Dec 2024: $3.7M published
Month from 1 Jan 2025: $1.1M published
Month from 1 Feb 2025: $657K published
Month from 1 Mar 2025: $3.0M published
Month from 1 Apr 2025: $1.0M published
Month from 1 May 2025: $1.1M published
Month from 1 Jun 2025: $2.1M published
Month from 1 Jul 2025: $3.3M published
Month from 1 Aug 2025: $4.4M published
Month from 1 Sep 2025: $8.3M published
Month from 1 Oct 2025: $3.2M published
Month from 1 Nov 2025: $180K published
Month from 1 Dec 2025: $2.8M published
Month from 1 Jan 2026: $359K published
Month from 1 Feb 2026: $1.3M published
Month from 1 Mar 2026: $2.1M published
Month from 1 Apr 2026: $1.7M published
Month from 1 May 2026: $2.7M published
Month from 1 Jun 2026: $2.3M published
Month from 1 Jul 2026: $2.1M published
Month from 1 Aug 2026: $4.5M published
Month from 1 Sep 2026: $4.7M published
Month from 1 Oct 2026: $2.0M published
Month from 1 Nov 2026: $378K published
Lobbying spend
Quarter from 1 Jan 2022: $1.4M published
Quarter from 1 Apr 2022: $2.1M published
Quarter from 1 Jul 2022: $1.8M published
Quarter from 1 Oct 2022: $1.5M published
Quarter from 1 Jan 2023: $1.4M published
Quarter from 1 Apr 2023: $1.3M published
Quarter from 1 Jul 2023: $1.6M published
Quarter from 1 Oct 2023: $440K published
Quarter from 1 Jan 2024: $510K published
Quarter from 1 Apr 2024: $380K published
Quarter from 1 Jul 2024: $270K published
Quarter from 1 Oct 2024: $300K published
Quarter from 1 Jan 2025: $450K published
Quarter from 1 Apr 2025: $670K published
Quarter from 1 Jul 2025: $460K published
Quarter from 1 Oct 2025: $430K published
Quarter from 1 Jan 2026: $330K published
Quarter from 1 Apr 2026: $320K published
Quarter from 1 Jul 2026: $300K published
Quarter from 1 Oct 2026: $240K published

What is unusual now

  • Made public in the last 90 days: it saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year; it also had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year.
  • Many funds opening a new position: saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year Public on 16 Nov 2026.
  • Short interest spike: had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year Public on 25 Sep 2026.
  • Insider net buying (open market): Insiders sold a net $720.6M in the last 12 months (the 12 months before: $1.6M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 5 sales, $270.2M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 Nov 2026Keith A. MeisterDirectorSell280,091$218.12$61.1MForm 4
12 Nov 2026Scott D EricksenVP, Chief Accounting OfficerSellplanned in advance (10b5-1)267$217.76$58KForm 4
5 Nov 2026Keith A. MeisterDirectorSell281,433$236.50$66.6MForm 4
4 Sep 2026Keith A. MeisterDirectorSell263,560$217.03$57.2MForm 4
27 Aug 2026Keith A. MeisterDirectorSell375,941$226.74$85.2MForm 4
21 Aug 2026Keith A. MeisterDirectorSell679,574$214.19$145.6MForm 4
20 Aug 2026Christensen Jakob WedelSVP, Strategy/Corp DevelopmentSellplanned in advance (10b5-1)1,033$191.52$198KForm 4
6 Aug 2026Keith A. MeisterDirectorSell741,127$199.91$148.2MForm 4

1,100 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 243 opened a position, 77 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)16.2M10.7%$4.4B+11.7M+258%
BlackRock, Inc.15.8M10.5%$4.3B-3.3M-17%
Vanguard Capital Management LLC9.9M6.54%$2.7B+3.3M+50%
Capital World Investors9.9M6.54%$2.7B-5.5M-36%
State Street Corp7.2M4.75%$2.0B+681K+10%
Vanguard Portfolio Management LLC6.3M4.20%$1.7B-284K-4.3%
WCM Investment Management, LLC5.7M3.79%$1.6B-473K-7.6%
JPMorgan Chase & Co4.9M3.27%$1.3B+3.8M+318%
Geode Capital Management, LLC4.2M2.79%$1.2B+1.3M+43%
Primecap Management Co3.5M2.31%$955.4M-24K-0.7%

Federal contracts

All 35 federal contracts

1 new award in 12 months, $1.3M obligated when signed. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
31 Jul 2026Department of Health and Human ServicesNational Institutes of Health$1.3MILLUMINA KITS FOR NIH INTRAMURAL SEQUENCING CENTER (NISC) POTS NUMBER : 26-003154USAspending
16 Sep 2024Department of Health and Human ServicesNational Institutes of Health$1.2MILLUMINA INC., TO PROVIDE REAGENTS AND CONSUMABLESUSAspending
16 May 2024Department of DefenseUniformed Services University of the Health Sciences$1.1MNOVASEQ X PLUS SEQUENCING SYSTEMUSAspending
1 Sep 2023Department of Health and Human ServicesNational Institutes of Health$1.8MILLUMINA AND CONSUMABLES REAGENTSUSAspending
5 Jun 2023Department of DefenseDepartment of the Air Force$1.3MRH - ILLUMINA NOVASEQ X PLUS SEQUENCING SYSTEMUSAspending
11 May 2023Department of Health and Human ServicesNational Institutes of Health$1.9MILLUMINA NOVASEQ X PLUS SEQUENCING SYSTEMUSAspending
20 Sep 2022Department of Health and Human ServicesNational Institutes of Health$2.1MILLUMINA REAGENTS FOR LIBRARY AND SEQUENCING REAGENTSUSAspending
29 Sep 2021Department of Veterans Affairs$1.6MORLANDO VA LAB NEXT GEN SEQUENCINGUSAspending

Company events

All 64 company events

In 12 months: 3 director or officer changes, 2 major agreements, 1 completed deal, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
13 Oct 2026Signed a major agreementSame filing: took on new debt8-K
13 Aug 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
23 Jun 2026Director or officer change8-K
2 Apr 2026Director or officer change8-K
30 Jan 2026Completed an acquisition or asset sale8-K
8 Jan 2026Director or officer change8-K
23 Jun 2025Signed a major agreement8-K
22 May 2025Director or officer changeSame filing: shareholder vote results8-K

170 open postings; careers site tracked since 22 Nov 2026.

PostedJobLocation
22 Nov 2026or earlierPartnering ManagerChina - Shanghai
22 Nov 2026or earlierSenior Manager PLM SolutionsIndia - Bengaluru - Manyata
22 Nov 2026or earlierAssociate Director - Pricing Transformation (San Diego/Hybrid)US - California - San Diego
22 Nov 2026or earlierSenior Software Quality EngineerIndia - Bengaluru - Manyata
22 Nov 2026or earlierManufacturing Technician 2Singapore - Woodlands - NorthTech
22 Nov 2026or earlierCRM Senior Business Systems AnalystMexico - Remote
22 Nov 2026or earlierInformatics Sales Specialist, JapanJapan - Tokyo
22 Nov 2026or earlierSr Data EngineerIndia - Bengaluru - Manyata

Reported lobbying spend: $240K in Q3 2026, $300K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2026NewThorn Run Partnersfor Illumina, Inc.FY27 House LHHS & Senate Defense Appropriations in relation to proteomics research.BudgetFiling
1 Jul 2025EndedS-3 Groupfor Actum Obo Illumina, Inc.Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies.; Issues and legislation related to tax reform and corporate tax policy; General discussion and monitoring of U.S. trade policyHealth issues, Taxation, TradeFiling
30 Jun 2025EndedFarragut Partners LLPfor IlluminaGeneral healthcare issues and competition issuesHealth issuesFiling
1 Jun 2025NewMiller Strategies, LLCfor Illumina, Inc.General issues related to trade.TradeFiling
31 Dec 2024EndedSidley Austin LLPfor Illumina, Inc.Not statedFiling
1 Sep 2024NewS-3 Groupfor Actum Obo Illumina, Inc.Issues and legislation related to US National security, genomic security and NDAAHealth issuesFiling
1 Apr 2024EndedDla Piper LLP (US)for Illumina, Inc.Not statedFiling
1 Mar 2024EndedAkin Gump Strauss Hauer & Feldfor Illumina, Inc.Issues related to S. 3558 - A bill to prohibit contracting with certain biotechnology providers, and for other purposes.Health issues, Homeland securityFiling

The 5 newest of 512 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

19 Nov 2024confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Illumina (ILMN): saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year, while it had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year. Two unrelated kinds of activity within 49 days.

  • Short interest and volume: Short interest spike, became public on 25 Oct 2024
  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2024
  • Short interest and volume: Short interest spike, became public on 13 Nov 2024
  • Short interest and volume: Short interest spike, became public on 11 Dec 2024
2022-09-30: 862022-12-31: 882023-03-31: 942023-06-30: 582023-09-30: 582023-12-31: 912024-03-31: 802024-06-30: 902024-09-30: 124
The quarter ended 30 Sep 2024 against the 8 quarters before it. this quarterearliernormal: 87
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 25 Oct 2024

Illumina had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.

This period
6.8M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.6
Same report last year
5.5M
History used
2,482 days
2023-10-13: 5.5M2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M
the 15 Oct 2024 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Nov 2024

Illumina saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.

This period
124 (the quarter ended 30 Sep 2024)
Normal quarter (median of 8 earlier)
87
Typical spread (median absolute deviation)
5.5
How far from its usual level
+4.3
Same quarter last year
58
History used
4,018 days
2022-09-30: 862022-12-31: 882023-03-31: 942023-06-30: 582023-09-30: 582023-12-31: 912024-03-31: 802024-06-30: 902024-09-30: 124
the quarter ended 30 Sep 20248 earlier quartersnormal: 87

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 13 Nov 2024

Illumina had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.

This period
6.7M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
307K
How far from its usual level
+3.5
Same report last year
5.2M
History used
2,498 days
2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M
the 31 Oct 2024 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Dec 2024

Illumina had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.

This period
7.2M (the 29 Nov 2024 report)
Normal report (median of 24 earlier)
5.0M
Typical spread (median absolute deviation)
312K
How far from its usual level
+4.5
Same report last year
5.0M
History used
2,527 days
2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M2024-11-15: 6.5M2024-11-29: 7.2M
the 29 Nov 2024 report24 earlier reportsnormal: 5.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

26 Jul 2022confirmed

Confirmed across sources Hiring and Lobbying and Short interest and volume

Illumina (ILMN): reported $1.8M of lobbying spend for the quarter ended 30 Jun 2022, 5.1× the same quarter last year; it also had 40 H-1B/E-3 visa applications certified in May 2022, 3.6× the same month last year; and it had 5.0M shares sold short in the 14 Oct 2022 report, 2.7× the same report last year. Three unrelated kinds of activity within 154 days.

  • Short interest and volume: Short interest spike, became public on 28 Jun 2022
  • Short interest and volume: Short interest spike, became public on 13 Jul 2022
  • Lobbying: Lobbying spend jump, became public on 19 Jul 2022
  • Short interest and volume: Short interest spike, became public on 27 Jul 2022
  • Short interest and volume: Short interest spike, became public on 25 Aug 2022
  • Short interest and volume: Short interest spike, became public on 13 Sep 2022
  • Short interest and volume: Short interest spike, became public on 27 Sep 2022
  • Hiring: H-1B/E-3 applications change, became public on 28 Sep 2022
  • Short interest and volume: Short interest spike, became public on 13 Oct 2022
  • Short interest and volume: Short interest spike, became public on 26 Oct 2022
  • Short interest and volume: Short interest spike, became public on 10 Nov 2022
  • Short interest and volume: Short interest spike, became public on 26 Nov 2022
2020-06-30: $170K2020-09-30: $340K2020-12-31: $340K2021-03-31: $340K2021-06-30: $360K2021-09-30: $1.5M2021-12-31: $1.4M2022-03-31: $2.1M2022-06-30: $1.8M
The quarter ended 30 Jun 2022 against the 8 quarters before it. this quarterearliernormal: $350K
See the evidence (12 changes)

Short interest and volume: Short interest spike became public on 28 Jun 2022

Illumina had 3.4M shares sold short in the 15 Jun 2022 report, 1.3× the same report last year.

This period
3.4M (the 15 Jun 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.2
Same report last year
2.7M
History used
1,629 days
2021-05-28: 2.8M2021-06-15: 2.7M2021-06-30: 2.6M2021-07-15: 2.4M2021-07-30: 2.2M2021-08-13: 2.2M2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M
the 15 Jun 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Jul 2022

Illumina had 3.9M shares sold short in the 30 Jun 2022 report, 1.5× the same report last year.

This period
3.9M (the 30 Jun 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+5.5
Same report last year
2.6M
History used
1,644 days
2021-06-15: 2.7M2021-06-30: 2.6M2021-07-15: 2.4M2021-07-30: 2.2M2021-08-13: 2.2M2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M
the 30 Jun 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying spend jump became public on 19 Jul 2022

Illumina reported $1.8M of lobbying spend for the quarter ended 30 Jun 2022, 5.1× the same quarter last year.

This period
$1.8M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$350K
Typical spread (median absolute deviation)
$95K
How far from its usual level
+10.5
Same quarter last year
$360K
History used
3,468 days
2020-06-30: $170K2020-09-30: $340K2020-12-31: $340K2021-03-31: $340K2021-06-30: $360K2021-09-30: $1.5M2021-12-31: $1.4M2022-03-31: $2.1M2022-06-30: $1.8M
the quarter ended 30 Jun 20228 earlier quartersnormal: $350K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Short interest and volume: Short interest spike became public on 27 Jul 2022

Illumina had 3.6M shares sold short in the 15 Jul 2022 report, 1.5× the same report last year.

This period
3.6M (the 15 Jul 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.6
Same report last year
2.4M
History used
1,659 days
2021-06-30: 2.6M2021-07-15: 2.4M2021-07-30: 2.2M2021-08-13: 2.2M2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M
the 15 Jul 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Aug 2022

Illumina had 3.5M shares sold short in the 15 Aug 2022 report, 1.6× the same report last year.

This period
3.5M (the 15 Aug 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
239K
How far from its usual level
+4.4
Same report last year
2.2M
History used
1,690 days
2021-07-30: 2.2M2021-08-13: 2.2M2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M
the 15 Aug 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Sep 2022

Illumina had 4.4M shares sold short in the 31 Aug 2022 report, 2.0× the same report last year.

This period
4.4M (the 31 Aug 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
255K
How far from its usual level
+6.4
Same report last year
2.2M
History used
1,706 days
2021-08-13: 2.2M2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M
the 31 Aug 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Sep 2022

Illumina had 4.4M shares sold short in the 15 Sep 2022 report, 1.8× the same report last year.

This period
4.4M (the 15 Sep 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
275K
How far from its usual level
+6.0
Same report last year
2.4M
History used
1,721 days
2021-08-31: 2.2M2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M2022-09-15: 4.4M
the 15 Sep 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Hiring: H-1B/E-3 applications change became public on 28 Sep 2022

Illumina had 40 H-1B/E-3 visa applications certified in May 2022, 3.6× the same month last year.

This period
40 (May 2022)
Normal month (median of 2 earlier)
9.5
Typical spread (median absolute deviation)
1.5
How far from its usual level
+10.2
Same month last year
11
History used
973 days
2020-05-01: 82021-05-01: 112022-05-01: 40
May 20222 earlier monthsnormal: 9.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least 20.

Check it at the source: DOL foreign labor disclosure data.

Short interest and volume: Short interest spike became public on 13 Oct 2022

Illumina had 4.3M shares sold short in the 30 Sep 2022 report, 2.1× the same report last year.

This period
4.3M (the 30 Sep 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
294K
How far from its usual level
+5.5
Same report last year
2.1M
History used
1,736 days
2021-09-15: 2.4M2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M2022-09-15: 4.4M2022-09-30: 4.3M
the 30 Sep 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Oct 2022

Illumina had 5.0M shares sold short in the 14 Oct 2022 report, 2.7× the same report last year.

This period
5.0M (the 14 Oct 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
294K
How far from its usual level
+7.0
Same report last year
1.8M
History used
1,750 days
2021-09-30: 2.1M2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M2022-09-15: 4.4M2022-09-30: 4.3M2022-10-14: 5.0M
the 14 Oct 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Nov 2022

Illumina had 4.8M shares sold short in the 31 Oct 2022 report, 2.3× the same report last year.

This period
4.8M (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
322K
How far from its usual level
+6.0
Same report last year
2.1M
History used
1,767 days
2021-10-15: 1.8M2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M2022-09-15: 4.4M2022-09-30: 4.3M2022-10-14: 5.0M2022-10-31: 4.8M
the 31 Oct 2022 report24 earlier reportsnormal: 1.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Nov 2022

Illumina had 4.4M shares sold short in the 15 Nov 2022 report, 2.5× the same report last year.

This period
4.4M (the 15 Nov 2022 report)
Normal report (median of 24 earlier)
2.0M
Typical spread (median absolute deviation)
444K
How far from its usual level
+3.5
Same report last year
1.7M
History used
1,782 days
2021-10-29: 2.1M2021-11-15: 1.7M2021-11-30: 1.8M2021-12-15: 1.7M2022-01-14: 1.8M2022-01-31: 1.6M2022-02-15: 1.6M2022-02-28: 1.7M2022-03-15: 1.7M2022-03-31: 1.6M2022-04-14: 1.6M2022-04-29: 1.8M2022-05-13: 2.0M2022-05-31: 2.5M2022-06-15: 3.4M2022-06-30: 3.9M2022-07-15: 3.6M2022-07-29: 3.0M2022-08-15: 3.5M2022-08-31: 4.4M2022-09-15: 4.4M2022-09-30: 4.3M2022-10-14: 5.0M2022-10-31: 4.8M2022-11-15: 4.4M
the 15 Nov 2022 report24 earlier reportsnormal: 2.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

26 Oct 2021confirmed

Confirmed across sources Government contracts and Lobbying

Illumina (ILMN): won its first award from the Department of Veterans Affairs, a $1.6M contract, after 27 earlier federal awards from other agencies, while it reported $1.5M of lobbying spend for the quarter ended 30 Sep 2021, 4.4× the same quarter last year. Two unrelated kinds of activity within 21 days.

  • Government contracts: First award from a new federal agency, became public on 5 Oct 2021
  • Lobbying: Lobbying spend jump, became public on 20 Oct 2021
2019-09-30: $160K2019-12-31: $190K2020-03-31: $180K2020-06-30: $170K2020-09-30: $340K2020-12-31: $340K2021-03-31: $340K2021-06-30: $360K2021-09-30: $1.5M
The quarter ended 30 Sep 2021 against the 8 quarters before it. this quarterearliernormal: $265K
See the evidence (2 changes)

Government contracts: First award from a new federal agency became public on 5 Oct 2021

Illumina won its first award from the Department of Veterans Affairs, a $1.6M contract, after 27 earlier federal awards from other agencies.

Source coverage starts
7 Oct 2007
Earlier events of other kinds
27

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Lobbying: Lobbying spend jump became public on 20 Oct 2021

Illumina reported $1.5M of lobbying spend for the quarter ended 30 Sep 2021, 4.4× the same quarter last year.

This period
$1.5M (the quarter ended 30 Sep 2021)
Normal quarter (median of 8 earlier)
$265K
Typical spread (median absolute deviation)
$80K
How far from its usual level
+10.4
Same quarter last year
$340K
History used
3,195 days
2019-09-30: $160K2019-12-31: $190K2020-03-31: $180K2020-06-30: $170K2020-09-30: $340K2020-12-31: $340K2021-03-31: $340K2021-06-30: $360K2021-09-30: $1.5M
the quarter ended 30 Sep 20218 earlier quartersnormal: $265K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 16 Nov 2026Institutional holdings change

    saw 245 13F filers open a new position in the quarter ended 30 Sep 2026, 2.6× the same quarter last year.

    Same quarter last year: 96; its normal quarter is 105.

    See the evidence
    This period
    245 (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    105
    Typical spread (median absolute deviation)
    23
    How far from its usual level
    +4.1
    Same quarter last year
    96
    History used
    4,748 days
    2024-09-30: 1242024-12-31: 1002025-03-31: 742025-06-30: 1102025-09-30: 962025-12-31: 1322026-03-31: 722026-06-30: 1482026-09-30: 245
    the quarter ended 30 Sep 20268 earlier quartersnormal: 105

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  2. 25 Sep 2026Short interest and volume change

    had 10.6M shares sold short in the 15 Sep 2026 report, 1.4× the same report last year.

    Same report last year: 7.3M; its normal report is 7.3M.

    See the evidence
    This period
    10.6M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    583K
    How far from its usual level
    +3.8
    Same report last year
    7.3M
    History used
    3,182 days
    2025-09-15: 7.3M2025-09-30: 6.6M2025-10-15: 6.7M2025-10-31: 6.7M2025-11-14: 6.5M2025-11-28: 7.1M2025-12-15: 7.4M2025-12-31: 6.8M2026-01-15: 6.5M2026-01-30: 8.3M2026-02-13: 7.9M2026-02-27: 7.2M2026-03-13: 7.2M2026-03-31: 7.0M2026-04-15: 7.2M2026-04-30: 6.5M2026-05-15: 7.5M2026-05-29: 7.7M2026-06-15: 9.2M2026-06-30: 7.6M2026-07-15: 8.8M2026-07-31: 8.1M2026-08-14: 9.5M2026-08-31: 9.7M2026-09-15: 10.6M
    the 15 Sep 2026 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 13 Aug 2026Filings record

    A major agreement ended

  4. 6 Aug 2026Government contracts record

    ILLUMINA, INC.: new Department of Health and Human Services contract 75N98026F00009 ($1.3M) (dated 31 Jul 2026)

  5. 23 Jun 2026Filings record

    Director or officer change

  6. 19 May 2026Attention change

    drew 6,435 Wikipedia page views in the week of 11 May 2026, 4.5× the same week last year.

    Same week last year: 1,434; its normal week is 846.

    See the evidence
    This period
    6,435 (the week of 11 May 2026)
    Normal week (median of 26 earlier)
    846
    Typical spread (median absolute deviation)
    70
    How far from its usual level
    +27.9
    Same week last year
    1,434
    History used
    2,638 days
    2025-11-10: 1,0892025-11-17: 9462025-11-24: 8712025-12-01: 9032025-12-08: 8392025-12-15: 7662025-12-22: 5872025-12-29: 5752026-01-05: 8972026-01-12: 9872026-01-19: 8372026-01-26: 9192026-02-02: 1,0662026-02-09: 8872026-02-16: 9272026-02-23: 9392026-03-02: 8642026-03-09: 7792026-03-16: 7672026-03-23: 7882026-03-30: 7072026-04-06: 8142026-04-13: 8142026-04-20: 8182026-04-27: 8542026-05-04: 7652026-05-11: 6,435
    the week of 11 May 202626 earlier weeksnormal: 846

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  7. 7 May 2026Lobbying record

    ILLUMINA, INC.: new lobbying registration (THORN RUN PARTNERS) (dated 1 Apr 2026)

  8. 2 Apr 2026Filings record

    Director or officer change

  9. 17 Feb 2026Financials change

    spent $55.0M on capital projects in the quarter ended 28 Dec 2025, 1.9× the same quarter last year.

    Same quarter last year: $29.0M; its normal quarter is $31.5M.

    See the evidence
    This period
    $55.0M (the quarter ended 28 Dec 2025)
    Normal quarter (median of 8 earlier)
    $31.5M
    Typical spread (median absolute deviation)
    $1.0M
    How far from its usual level
    +7.5
    Same quarter last year
    $29.0M
    History used
    5,936 days
    2023-12-31: $51.0M2024-03-31: $36.0M2024-06-30: $31.0M2024-09-29: $32.0M2024-12-29: $29.0M2025-03-30: $32.0M2025-06-29: $30.0M2025-09-28: $31.0M2025-12-28: $55.0M
    the quarter ended 28 Dec 20258 earlier quartersnormal: $31.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  10. 12 Feb 2026Insiders record

    Gottlieb Scott (director) bought 200 shares of ILMN ($23,562) (dated 11 Feb 2026)

  11. 30 Jan 2026Filings record

    Completed an acquisition or asset sale

  12. 13 Jan 2026Lobbying record

    ACTUM OBO ILLUMINA, INC.: lobbying engagement terminated (S-3 GROUP) (dated 1 Jul 2025)

  13. 8 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 8 Jan 2026Filings record

    Director or officer change

  15. 6 Nov 2025Insiders record

    Gottlieb Scott (director) bought 500 shares of ILMN ($61,065) (dated 5 Nov 2025)

  16. 20 Oct 2025Lobbying record

    ILLUMINA: lobbying engagement terminated (FARRAGUT PARTNERS LLP) (dated 30 Jun 2025)

  17. 10 Jul 2025Lobbying record

    ILLUMINA, INC.: new lobbying registration (MILLER STRATEGIES, LLC) (dated 1 Jun 2025)

  18. 22 May 2025Filings record

    Director or officer change

  19. 15 May 2025Insiders record

    Thaysen Jacob (Chief Executive Officer) bought 12,350 shares of ILMN ($998,674) (dated 14 May 2025)

  20. 15 May 2025Insiders record

    Dhingra Ankur (SVP, Chief Financial Officer) bought 6,100 shares of ILMN ($495,381) (dated 14 May 2025)

  21. 25 Mar 2025Filings record

    Director or officer change

  22. 24 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 24 Mar 2025Filings record

    Director or officer change

  24. 11 Feb 2025Attention change

    drew 5,355 Wikipedia page views in the week of 3 Feb 2025, 3.5× the same week last year.

    Same week last year: 1,522; its normal week is 1,291.

    See the evidence
    This period
    5,355 (the week of 3 Feb 2025)
    Normal week (median of 26 earlier)
    1,291
    Typical spread (median absolute deviation)
    76.5
    How far from its usual level
    +20.3
    Same week last year
    1,522
    History used
    2,176 days
    2024-08-05: 1,1812024-08-12: 1,2412024-08-19: 1,3092024-08-26: 1,1972024-09-02: 1,2782024-09-09: 1,2202024-09-16: 1,3302024-09-23: 1,1982024-09-30: 1,3932024-10-07: 1,3352024-10-14: 1,2942024-10-21: 1,2882024-10-28: 1,1612024-11-04: 1,2382024-11-11: 1,3732024-11-18: 1,3282024-11-25: 1,2742024-12-02: 1,3802024-12-09: 1,3482024-12-16: 1,1612024-12-23: 8792024-12-30: 8342025-01-06: 1,4582025-01-13: 1,6312025-01-20: 1,5272025-01-27: 1,3142025-02-03: 5,355
    the week of 3 Feb 202526 earlier weeksnormal: 1,291

    Fires when the period is at least 5.0 robust standard deviations above the company's own median, with 20+ earlier periods, 365+ days of history and a value of at least 5,000.

    Check it at the source: Wikimedia page view statistics.

  25. 17 Jan 2025Lobbying record

    ILLUMINA, INC.: lobbying engagement terminated (SIDLEY AUSTIN LLP) (dated 31 Dec 2024)

  26. 11 Dec 2024Short interest and volume change

    had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.

    Same report last year: 5.0M; its normal report is 5.0M.

    See the evidence
    This period
    7.2M (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    312K
    How far from its usual level
    +4.5
    Same report last year
    5.0M
    History used
    2,527 days
    2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M2024-11-15: 6.5M2024-11-29: 7.2M
    the 29 Nov 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 19 Nov 2024several at once

    saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year, while it had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year. Two unrelated kinds of activity within 49 days.

    See the evidence (4 changes)

    Short interest and volume: Short interest spike became public on 25 Oct 2024

    Illumina had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.

    This period
    6.8M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    307K
    How far from its usual level
    +3.6
    Same report last year
    5.5M
    History used
    2,482 days
    2023-10-13: 5.5M2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M
    the 15 Oct 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Nov 2024

    Illumina saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.

    This period
    124 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    87
    Typical spread (median absolute deviation)
    5.5
    How far from its usual level
    +4.3
    Same quarter last year
    58
    History used
    4,018 days
    2022-09-30: 862022-12-31: 882023-03-31: 942023-06-30: 582023-09-30: 582023-12-31: 912024-03-31: 802024-06-30: 902024-09-30: 124
    the quarter ended 30 Sep 20248 earlier quartersnormal: 87

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 13 Nov 2024

    Illumina had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.

    This period
    6.7M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    307K
    How far from its usual level
    +3.5
    Same report last year
    5.2M
    History used
    2,498 days
    2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M
    the 31 Oct 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Dec 2024

    Illumina had 7.2M shares sold short in the 29 Nov 2024 report, 1.4× the same report last year.

    This period
    7.2M (the 29 Nov 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    312K
    How far from its usual level
    +4.5
    Same report last year
    5.0M
    History used
    2,527 days
    2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M2024-11-15: 6.5M2024-11-29: 7.2M
    the 29 Nov 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  28. 14 Nov 2024Institutional holdings change

    saw 124 13F filers open a new position in the quarter ended 30 Sep 2024, 2.1× the same quarter last year.

    Same quarter last year: 58; its normal quarter is 87.

    See the evidence
    This period
    124 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    87
    Typical spread (median absolute deviation)
    5.5
    How far from its usual level
    +4.3
    Same quarter last year
    58
    History used
    4,018 days
    2022-09-30: 862022-12-31: 882023-03-31: 942023-06-30: 582023-09-30: 582023-12-31: 912024-03-31: 802024-06-30: 902024-09-30: 124
    the quarter ended 30 Sep 20248 earlier quartersnormal: 87

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  29. 13 Nov 2024Short interest and volume change

    had 6.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.

    Same report last year: 5.2M; its normal report is 5.0M.

    See the evidence
    This period
    6.7M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    307K
    How far from its usual level
    +3.5
    Same report last year
    5.2M
    History used
    2,498 days
    2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M2024-10-31: 6.7M
    the 31 Oct 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 25 Oct 2024Short interest and volume change

    had 6.8M shares sold short in the 15 Oct 2024 report, 1.2× the same report last year.

    Same report last year: 5.5M; its normal report is 5.0M.

    See the evidence
    This period
    6.8M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.0M
    Typical spread (median absolute deviation)
    307K
    How far from its usual level
    +3.6
    Same report last year
    5.5M
    History used
    2,482 days
    2023-10-13: 5.5M2023-10-31: 5.2M2023-11-15: 5.4M2023-11-30: 5.0M2023-12-15: 4.0M2023-12-29: 4.3M2024-01-12: 4.7M2024-01-31: 4.7M2024-02-15: 4.8M2024-02-29: 4.9M2024-03-15: 5.2M2024-03-28: 5.3M2024-04-15: 5.3M2024-04-30: 4.8M2024-05-15: 5.4M2024-05-31: 5.8M2024-06-14: 5.1M2024-06-28: 5.0M2024-07-15: 4.8M2024-07-31: 4.7M2024-08-15: 4.2M2024-08-30: 4.5M2024-09-13: 4.9M2024-09-30: 5.5M2024-10-15: 6.8M
    the 15 Oct 2024 report24 earlier reportsnormal: 5.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 23 Oct 2024Lobbying record

    ACTUM OBO ILLUMINA, INC.: new lobbying registration (S-3 GROUP) (dated 1 Sep 2024)

  32. 3 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 3 Oct 2024Filings record

    Director or officer change

  34. 22 Sep 2024Government contracts record

    ILLUMINA, INC.: new Department of Health and Human Services contract 75N92024F00012 ($1.2M) (dated 16 Sep 2024)

  35. 9 Sep 2024Filings record

    A major agreement ended

  36. 16 Aug 2024Government contracts record

    ILLUMINA, INC.: new Department of Defense contract HU000124P0035 ($1.1M) (dated 16 May 2024)

  37. 22 Jul 2024Lobbying record

    ILLUMINA, INC.: lobbying engagement terminated (DLA PIPER LLP (US)) (dated 1 Apr 2024)

  38. 24 Jun 2024Filings record

    Completed an acquisition or asset sale

  39. 3 Jun 2024Filings record

    Restructuring costs announced

  40. 19 Apr 2024Lobbying record

    ILLUMINA, INC.: lobbying engagement terminated (AKIN GUMP STRAUSS HAUER & FELD) (dated 1 Mar 2024)

Showing the newest 40 of 183 entries; narrow the window or the kind of data to see older ones.

Not listed: 592 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001110803
Ticker
ILMN
Domain
illumina.com
Employer name
fluent biosciences, Illumina, Inc., illumina software, illumina technology solutions and 1 more (5 unverified)
Fein
01-0577067 (1 unverified)
Hq location
CA|SAN DIEGO|92122 (1 unverified)
Lobbying client
actum obo illumina, dla piper llp us on behalf of illumina, illumina, paul hastings llp on behalf of illumina
Name
Advanced Liquid Logic Inc, BlueBee Holding BV, Emedgene Technologies Ltd, Fluent Biosciences Inc and 39 more
Uei
KMW3CRWNAAF3
Wikidata
Q2068984
Wikipedia
Illumina, Inc.
  • DOL H-1B labor condition applications and PERM certifications1610 data points1 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)33 records, 137 data points20 Nov 2012 to 30 Sep 2026
  • SEC Form 13F institutional holdings5 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)203 records14 Jan 2016 to 30 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1331 data points30 Dec 2007 to 23 Oct 2026
  • SEC Form 4 insider transactions444 records, 1316 data points4 Jan 2016 to 12 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards35 records, 11898 data points4 Oct 2007 to 20 Nov 2026
  • Wikipedia pageviews2827 data points25 Feb 2019 to 21 Nov 2026